Global Stock News

Pfizer Stock: Wall Street Sees a Rebound, Here’s Our Price Target

Pfizer Stock: Wall Street Sees a Rebound, Here’s Our Price Target

Pfizer Stock: Wall Street Sees a Rebound, Here’s Our Price Target

© tupungato / iStock Editorial via Getty Images

Our 24/7 Wall St. price target for Pfizer (NYSE:PFE | PFE Price Prediction) points to $32.36 over the next 12 months, implying 15.27% upside from the recent close of $28.07. Our recommendation is buy, with high model confidence of 90%. Pipeline momentum, a re-rated 2026 guide, and a 6.19% dividend yield tip the scale toward a rebound thesis.


An infographic titled '24/7 Wall St. 12-Month Price Prediction Pfizer PFE'. It displays a 'BUY' recommendation for Pfizer stock with a current price of $28.07, a price target of $32.36, and an implied upside of 15.27% at a 90% confidence level. The infographic breaks down 'How We Got There' with analyst consensus ($28.61, 30% weight), forward P/E-based price ($30.12), and trailing P/E-based price ($28.07), resulting in a weighted base price of $29.26. 'Our Adjustments' section shows a bar chart illustrating additive factors like volatility (+0.014), price position (+0.015), and subtractive factors like social sentiment (-0.036) and earnings growth (-0.01), with a 247Factor Adjustment of 1.106x leading to the final target. The 'Bull Case (Green Section)' lists positive factors: oncology momentum, obesity pipeline, and cost savings, with a target of $36.17. The 'Bear Case (Red Section)' lists negative factors: COVID revenue collapse, generic competition, and unused share repurchases, with a target of $28.60. The 'Bottom Line' reiterates 'BUY' at $32.36 with 15.27% upside, citing pipeline momentum, a re-rated 2026 guide, and a 6.19% dividend yield.

24/7 Wall St.










Metric Value
Current Price $28.07
24/7 Wall St. Price Target $32.36
Upside 15.27%
Recommendation BUY
Confidence Level 90%


A Quiet Rebound Is Already Underway

Pfizer has quietly become one of healthcare’s better price stories in 2026. Shares are up 18.58% year to date…

Source link

Share this article

Scroll to Top